LeMaitre Vascular, Inc. (LMAT) Comparison with companies in other sectors?

LeMaitre Vascular, Inc. has a share price of 22.59M. You can analyze LeMaitre Vascular, Inc. (LMAT) competitors across different market sectors through stock heatmaps.

What are LMAT's NET and operating margins?

LeMaitre Vascular, Inc. (LMAT) operating margin is around 0.23, and net profit margin is approximately 0.20 as of the latest reports.

In what way does LMAT's earnings per share (EPS) trend reflect its financial momentum?

LeMaitre Vascular, Inc. (LMAT) EPS is 1.97 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for LeMaitre Vascular, Inc. is 41.92, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for LeMaitre Vascular, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for LeMaitre Vascular, Inc. like P/E which is 41.18, P/B which is 5.35, and PEG which is 16.23. Compare them with sector averages to evaluate if the stock is priced fairly.

LeMaitre Vascular, Inc.

LMAT•NASDAQ

Healthcare

Medical - Instruments & Supplies

$82.43

$1.66(2.06%)

Fundamental Analysis of LeMaitre Vascular, Inc. (LMAT)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$1.97

P/E Ratio

41.92

ROE

0.14%

Net Margin

0.20%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.87B

Shares OutstandingTotal number of shares issued

$22.59M

Book Value/ShareNet worth per share

$15.40

Revenue/ShareAnnual revenue per share

$10.02

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.97

Net MarginNet income as percentage of revenue

19.96%

Operating MarginOperating income as percentage of revenue

23.43%

ROEReturn on shareholders' equity

13.53%

ROAReturn on total assets

8.12%

ROCEReturn on capital employed

9.98%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.82

Cash/ShareCash and equivalents per share

$13.40

FCF YieldFree cash flow as percentage of market cap

2.21%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.72

Dividend YieldAnnual dividend as percentage of stock price

0.87%

Financial Ratios Analysis data is not available for LMATFinancial Ratios Analysis details for LMAT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for LMATSector Benchmarking details for LMAT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for LeMaitre Vascular, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of LeMaitre Vascular, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account LeMaitre Vascular, Inc.'s unique business strengths and challenges.

Key Financial Metrics for LeMaitre Vascular, Inc.

For LeMaitre Vascular, Inc., essential financial indicators include EPS 1.97, PE 41.92, and ROE 0.14. These key ratios reveal insights into LeMaitre Vascular, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare LeMaitre Vascular, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of LeMaitre Vascular, Inc.

Metrics like Net Margin 19.96% and ROA 8.12% shed light on how well LeMaitre Vascular, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether LeMaitre Vascular, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of LeMaitre Vascular, Inc.

Using ratios such as P/B Ratio 5.35 and PEG Ratio 16.23, investors can assess whether LeMaitre Vascular, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with LeMaitre Vascular, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for LeMaitre Vascular, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.53 and Cash Flow $1.82, provide a snapshot of LeMaitre Vascular, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like LeMaitre Vascular, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for LeMaitre Vascular, Inc.

Investing in LeMaitre Vascular, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at LeMaitre Vascular, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;